Karolinska Development AB  

(Public, STO:KDEV)   Watch this stock  
Find more results for KDEV
-0.03 (-0.60%)
Real-time:   12:00PM GMT+2
STO real-time data - Disclaimer
Currency in SEK
Range 4.97 - 5.00
52 week 4.78 - 8.10
Open 5.00
Vol / Avg. 1,895.00/24,977.00
Mkt cap 312.28M
P/E     -
Div/yield     -
EPS -2.67
Shares 51.72M
Beta     -
Inst. own     -
Aug 29, 2017
Q2 2017 Karolinska Development AB Earnings Release Add to calendar
May 24, 2017
Karolinska Development AB Annual Shareholders Meeting
May 17, 2017
Q1 2017 Karolinska Development AB Earnings Call - Webcast
May 16, 2017
Q1 2017 Karolinska Development AB Earnings Release

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin -4089.12% -4045.37%
Operating margin -2156.82% -3247.18%
EBITD margin - -511.18%
Return on average assets -23.42% -41.19%
Return on average equity -218.17% -156.16%
Employees 6 -
CDP Score - -


Tomtebodavagen 23 A
SOLNA, 171 65
+46-8-52486070 (Phone)

Website links


Karolinska Development AB is a Sweden-based investment company. The Company provides capital to biotechnology firms, as well as develops and commercializes biotechnological products. Its activities are involved in a range of areas: oncology, infections and wound healing, women’s health, cardiovascular and hematology, medical equipment, diagnostics, pharmaceutical formulation, as well as implants, among others. The Company’s pharmaceuticals portfolio comprises: AXL1717 for non-small-cell lung carcinoma (NSCLC), APR-246 for ovarian cancer, Sevuparin for malaria, SHACT for pain relief at hysteroscopy and intrauterine device (IUD) insertion, and PC-mAB for acute coronary syndrome (ACS), among others. Furthermore, the Company controls a number of subsidiaries, such as Avaris AB, HBV Thernostica AB, KD Incentive AB, KDev Oncology AB and Limone AB.

Officers and directors

Niclas Adler Chairman of the Board
Age: 46
Jim Van Heusden Ph.D. Chief Executive Officer
Age: 45
Viktor Drvota M.D., Ph.D. Deputy Chief Executive Officer, Chief Investment Officer
Age: 52
Tse Ping Independent Vice Chairman of the Board
Age: 64
Christian H. Tange Chief Financial Officer
Age: 50
Eva Montgomerie Head of Accounting
Age: 58
Ulf Richenberg General Counsel
Age: 61
Elisabet Gimbringer Controller
Age: 51
Anders Harfstrand Director
Age: 61
Hans-Olov Olsson Director
Age: 76